Citation 106213

WALDMEIER,PC: WICKI,P: FROESTL,WG: BITTIGER,H: FELDTRAUER,JJ: BAUMANN,PA:. (1995). EFFECTS OF THE PUTATIVE P-TYPE CALCIUM CHANNEL BLOCKER, R,R-(-)-DAURISOLINE ON NEUROTRANSMITTER RELEASE.. 352(6)

Citation Details

Title	EFFECTS OF THE PUTATIVE P-TYPE CALCIUM CHANNEL BLOCKER, R,R-(-)-DAURISOLINE ON NEUROTRANSMITTER RELEASE.
Authors	WALDMEIER,PC: WICKI,P: FROESTL,WG: BITTIGER,H: FELDTRAUER,JJ: BAUMANN,PA:
Year	1995
Volume	352
Issue	6

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	MUSCARINIC RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
2	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
3	OPIATE RECEPTOR BINDING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
4	GABA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
5	GLUTAMATE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
6	NOREPINEPHRINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
7	DOPAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
8	SEROTONIN (5-HT) SECRETION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
9	ACH RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
10	ADRENERGIC RECEPTOR BLOCKER(ALPHA-1)	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE
11	ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)	PHARMACOLOGY OF COMPOUND - IN VITRO	DAURISOLINE,(-): (R-R):	ACTIVE

Show SPARQL Queries (1)